Pharmaceutical Regulatory Affairs in Chile

Your portfolio.
Structured
for Chile.

From pharmaceutical dossiers to a local operating structure. Senior regulatory direction, built around what your company needs next.

Based in Chile. Working with international teams.

Built around your portfolio
Product registrations

Product-specific dossier work, coordinated from review through submission and agreed follow-up.

ISP pharmaceutical submission supportCTD dossier reviewChile Ministry of Health pathway mapping
What we do

Regulatory expertise.
Connected to your operation.

Each engagement starts from the regulatory need. The delivery model then adapts to one dossier, a portfolio or an ongoing operating requirement.

How we deliver

From one dossier
to ongoing operations.

Your regulatory need defines the work. DBD, ENTRY Chile and OPERATE adapt its delivery to your products, portfolio and ongoing responsibilities.

DBD

Defined dossier work

One or a few products, with bounded deliverables, review cycles and milestones.

Best fit
Clearly identified products and dossier work.
ENTRY Chile

Portfolio execution

A prioritized portfolio advanced in agreed waves from a common baseline.

Best fit
Several products requiring sequencing and shared governance.
OPERATE

Regulatory continuity

A configurable service catalogue for a defined inventory, period and capacity.

Best fit
Ongoing lifecycle responsibilities after the initial scope.
Your starting point

What do you need
to put in place in Chile?

Choose an objective to see the relevant service and what to prepare.

A useful starting point

Start with the products and their dossiers.

A product-specific registration scope can cover dossier review, document coordination, submission and agreed follow-up.

For an initial conversation

  • Products and dosage forms
  • Manufacturers and manufacturing sites
  • Current dossier status and intended portfolio
Dose Dumping / ENGuide to pharmaceutical registration

Share a non-confidential overview. This guide helps you navigate our services; product eligibility and the scope of work require individual review.

BALinkedIn ↗
Founder-led

Senior regulatory direction stays close to the work.

Boris Araya Ibarra leads critical regulatory decisions, the primary client relationship and final review of work delivered under SERTURNER's responsibility.

About SERTURNER →Connect with Boris on LinkedIn ↗
Published by SERTURNER

Dose Dumping

Monthly pharmaceutical industry intelligence

For decision-makers: Chilean market developments in Spanish and regulatory guidance for international teams in English.

Chile, made workable

Define the next controlled step.

Share a non-confidential overview of your products, dossier baseline and intended local structure.

Start a conversation